EcoR1 Capital, LLC's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 21, 2025
- Accession no.
- 0000935836-25-000074
- Filed
- Jan 21, 2025
- Trade date
- Jan 16-17, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $1.96M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Common Stock | PPurchaseAcquired | +121,681 | $13.89 | +$1,690,149.09 | 15,700,413 | Indirect | |
| Jan 17, 2025 | Common Stock | PPurchaseAcquired | +19,748 | $13.87 | +$273,904.76 | 15,720,161 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Scott Platshon, an employee of EcoR1, serves as a director of the Issuer and was nominated for the board by EcoR1 and the Funds.